Skip to content

Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units

Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units: A Randomized, Controlled, Cluster, Crossover Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07233837
Acronym
Hylight
Enrollment
5000
Registered
2025-11-18
Start date
2026-01-05
Completion date
2027-03-01
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antimicrobial, Catheter Related Blood Stream Infections, Infection, Hospital, Pneumonia Associated With Mechanical Ventilation, Urinary Tract Infection(UTI)

Keywords

Healthcare associated infections, Antimicrobial use, Intensive care units, pneumonia, ventilator-associated, Catheter-related infections, Urinary tract infections, Hydrogen Peroxide, Ultraviolet light

Brief summary

Healthcare-associated infections (HAIs) remain a major problem in intensive care units (ICUs), driven by environmental contamination with multidrug-resistant organisms that persist despite routine manual cleaning. While hydrogen peroxide aerosolization and ultraviolet-C light devices have shown promise in reducing surface contamination, current evidence is inconsistent, mostly derived from single-center studies, and rarely linked to patient-centered outcomes. The investigators will conduct this cluster-randomized, crossover trial in 12 Brazilian ICUs. Each ICU will sequentially implement three strategies: (1) usual surface disinfection; (2) usual surface disinfection followed by hydrogen peroxide aerosolization at 7.9% concentration, applied through a dedicated device inside a protective tent during terminal cleaning of patient beds; and (3) usual surface disinfection followed by automated ultraviolet-C irradiation, also applied under the same tent to shield adjacent occupied beds. The primary outcome will be the antimicrobial utilization, measured as daily defined doses (DDD) of antimicrobials at the ICU level per 100 patient-days, with secondary outcomes including HAI incidence rate, environmental contamination with multidrug-resistant organisms, specific HAIs incidence rate (associated-ventilator pneumonia, central-line associated bloodstream infection, and catheter-associated urinary tract infection), and ICU length of stay costs.

Interventions

OTHERAerosol of hydrogen peroxide

Spray of aerosolized peroxide hydrogen using a specific device when performing terminal cleaning of the ICU bed after the patient's discharge.

OTHERIrradiation of ultraviolet light

Irradiation of UV light for the purpose of disinfecting beds and surfaces near beds during terminal cleaning.

Sponsors

Hospital Israelita Albert Einstein
Lead SponsorOTHER
Hospital Sirio-Libanes
CollaboratorOTHER
Hospital do Coracao
CollaboratorOTHER
Beneficência Portuguesa de São Paulo
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Randomized, controlled, cluster, crossover, trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients aged 18 years and older who will be admitted to the participating ICUs

Exclusion criteria

* Patients under 18 years * ICUs that use peroxide hydrogen or ultraviolet light for surface disinfection as part of their protocol

Design outcomes

Primary

MeasureTime frameDescription
Antimicrobial utilization at the ICU level3 monthsAntimicrobial utilization, measured as daily defined doses (DDD) of antimicrobials at the ICU level per 100 patient-days

Secondary

MeasureTime frameDescription
Healthcare-associated infections3 monthsIncidence rate of device healthcare-associated infections during ICU admission
Contamination of environmental surfaces by multi-resistant microorganisms3 monthsWe will collect environmental samples from 4 surfaces highly touched by the patient, health team and family (bed rails, monitor and infusion pump buttons, meal table or procedure table, and IV drip stand) before and after the intervention. For analysis of the environmental samples, characterization of the density and microbiological profile of biofilms on the different surfaces of the ICU beds will be performed using large-scale DNA sequencing techniques associated with bioinformatics analysis.
Incidence density of ventilator-associated pneumonia3 months
Incidence density of central line-associated bloodstream infections3 months
Incidence density of catheter-associated urinary tract infection3 months
Intensive care unit length of stay costs3 months

Countries

Brazil

Contacts

CONTACTAntonio P Nassar Jr, PhD
antonio.nassar@einstein.br551121519617
CONTACTAdriano J Pereira, PhD
Adriano.Pereira2@einstein.br551121519617
PRINCIPAL_INVESTIGATORAntonio P Nassar Jr, PhD

Hospital Israelita Albert Einstein

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026